Composition for Treating Uterine Fibroid (SB-UF)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2021

Study Completion Date

February 1, 2021

Conditions

Uterine Fibroids Affecting Pregnancy

Interventions

DRUG

SB-UF

"Dosage:~-Take 1tablet/2 times/day/in throughout pregnancy."

DEVICE

SB-UF Placebo

"Dosage:~-Take 1tablet/2 times/day/in throughout pregnancy."

Trial Locations (2)

Saigon Biopharma Company Limited, Ho Chi Minh City

Saigon Biopharma LLC, Wilmington

All Listed Sponsors

collaborator

TRAN MINH DUC, MD

UNKNOWN

collaborator

Tran Minh Cam Tu, MD

UNKNOWN

lead

Trieu, Nguyen Thi, M.D.

INDIV

NCT04762316 - Composition for Treating Uterine Fibroid (SB-UF) | Biotech Hunter | Biotech Hunter